Manufacturer
Eli Lilly and Company NDC Codes
Finished products listed with the FDA under labeler names that contain “Eli Lilly”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Rezvoglar KwikPeninsulin glargine-aglr | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8980 |
| Sterile Diluentdiluent | Water 1 mL/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-0800 |
| Stratteraatomoxetine hydrochloride | Atomoxetine hydrochloride 10 mg/1 | CapsuleOral | Eli Lilly and Company | 0002-3227 |
| Stratteraatomoxetine hydrochloride | Atomoxetine hydrochloride 25 mg/1 | CapsuleOral | Eli Lilly and Company | 0002-3228 |
| Stratteraatomoxetine hydrochloride | Atomoxetine hydrochloride 40 mg/1 | CapsuleOral | Eli Lilly and Company | 0002-3229 |
| Stratteraatomoxetine hydrochloride | Atomoxetine hydrochloride 18 mg/1 | CapsuleOral | Eli Lilly and Company | 0002-3238 |
| Stratteraatomoxetine hydrochloride | Atomoxetine hydrochloride 60 mg/1 | CapsuleOral | Eli Lilly and Company | 0002-3239 |
| Stratteraatomoxetine hydrochloride | Atomoxetine hydrochloride 80 mg/1 | CapsuleOral | Eli Lilly and Company | 0002-3250 |
| Stratteraatomoxetine hydrochloride | Atomoxetine hydrochloride 100 mg/1 | CapsuleOral | Eli Lilly and Company | 0002-3251 |
| Taltzixekizumab | Ixekizumab 80 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1445 |
| Taltzixekizumab | Ixekizumab 80 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-7724 |
| Taltzixekizumab | Ixekizumab 20 mg/.25mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8900 |
| Taltzixekizumab | Ixekizumab 40 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8905 |
| Tauvidflortaucipir f-18 | Flortaucipir f-18 100 mCi/mL | Injection, SolutionIntravenous | Eli Lilly and Company | 0002-1220 |
| Trulicitydulaglutide | Dulaglutide .75 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1433 |
| Trulicitydulaglutide | Dulaglutide 1.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1434 |
| Trulicitydulaglutide | Dulaglutide 3 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2236 |
| Trulicitydulaglutide | Dulaglutide 4.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3182 |
| Verzenioabemaciclib | Abemaciclib 50 mg/1 | TabletOral | Eli Lilly and Company | 0002-4483 |
| Verzenioabemaciclib | Abemaciclib 100 mg/1 | TabletOral | Eli Lilly and Company | 0002-4815 |
| Verzenioabemaciclib | Abemaciclib 150 mg/1 | TabletOral | Eli Lilly and Company | 0002-5337 |
| Verzenioabemaciclib | Abemaciclib 200 mg/1 | TabletOral | Eli Lilly and Company | 0002-6216 |
| Zepboundtirzepatide | Tirzepatide 2.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-0152 |
| Zepboundtirzepatide | Tirzepatide 5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-0243 |
| Zepboundtirzepatide | Tirzepatide 7.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1214 |